spacer
home > ict > autumn 2017 > perfect planning
PUBLICATIONS
International Clinical Trials

Perfect Planning

The cell and gene therapies being developed today have the potential to cure diseases. To make those treatments possible, another industry has to evolve: logistics. In the past two decades, gene-based clinical trials have increased by almost 500%. The global market for regenerative medicines – including cell therapies, gene/gene-modified cell therapy and tissue engineering – is poised to reach $67 billion in 2020.

While the majority of cell and gene therapies are still experimental – aimed at rare single-gene disorders – researchers hope to build on their successes to develop treatments for multi-gene disorders, including heart disease, hypertension, diabetes, arthritis and Alzheimer’s. This makes the success of clinical trials now vitally important to humanity. However, therein lies the challenge. Unlike traditional medicines, these therapies contain living cells or viral vectors that must be protected to ensure their survival and effectiveness.

Therapies that contain these materials are produced and packaged under strictly controlled conditions. They must be transported around the world and delivered on time at optimum temperature to ensure they arrive in perfect condition. This must be done regardless of weather, traffic, mechanical difficulties, staffing irregularities, customs regulations or processing delays.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Lisa Vocat is Global Content Marketing Manager at World Courier, part of AmerisourceBergen’s global specialty logistics business. She is responsible for World Courier’s content marketing strategy and thought leadership development.
spacer
Lisa Vocat
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

HATRIC-based identification of receptors for orphan ligands (small molecules)

HATRIC-LRC (Ligand Receptor Capture) enables now the identification of small molecule targets on the surface of living cells! Even primary cells!
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

PPMA SHOW 2018

25-27 September 2018, NEC, Birmingham, UK

The UK’s leading production line event is celebrating its 30th Anniversary. Taking place at the NEC, Birmingham from 25-27 September 2018, the exhibition showcases the latest processing and packaging machinery. Attended by thousands of manufacturers of food, pharmaceuticals and FMCG as well as contract packers and more.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement